Abstract
Persistent pulmonary hypertension of the newborn more often affects term and near-term infants. It occurs when the anticipated postnatal decrease in pulmonary vascular resistance fails to occur. There is evidence in animal models of premature ductal closure and persistent pulmonary hypertension of the newborn in fetal mice with in-utero exposure to selective serotonin reuptake inhibitors, commonly prescribed antidepressants in pregnancy. This case raises suspicion about an association in a neonate between in-utero exposure to selective serotonin reuptake inhibitors and persistent pulmonary hypertension of the newborn secondary to premature ductal closure.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.